derrierloisirs.fr
» » Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance

Download Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance ePub

by World Health Organization

Download Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance ePub
  • ISBN 9241563613
  • ISBN13 978-9241563611
  • Language English
  • Author World Health Organization
  • Publisher World Health Organization; 4 edition (March 31, 2009)
  • Pages 151
  • Formats lrf txt doc mbr
  • Category Medicine
  • Subcategory Medicine
  • Size ePub 1573 kb
  • Size Fb2 1359 kb
  • Rating: 4.2
  • Votes: 310

Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to this new report that presents findings from the largest survey to date on the scale of drug resistance in tuberculosis.This fourth global report is based on information collected between 2002 and 2006 on 90,000 TB patients in 81countries. It also found that extensively drug-resistant tuberculosis (XDR-TB), a virtually untreatable form of therespiratory disease, has been recorded in 45 countries. The primary aim of this report is to share survey and surveillance data on drug resistance in TB. The data presented here are supplied largely by the program managers who have led the work on surveys, but also heads of reference laboratories as well as principle investigators that may have been hired to assist the national Tuberculosis Program with the study.

The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007.

The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]

The WHO (World Health Organization) and the IUATLD (International Union Against Tuberculosis and Lung Disease) have established a global project of drug resistance surveillance that is based on standard epidemiological methods and quality control through an extensive network o. .

The WHO (World Health Organization) and the IUATLD (International Union Against Tuberculosis and Lung Disease) have established a global project of drug resistance surveillance that is based on standard epidemiological methods and quality control through an extensive network of reference laboratories. Accurate drug resistance surveillance data can be used to assess and improve national tuberculosis programs.

The constitution of the World Health O The World Health Organization (WHO) is a specialized agency of the United Nations that is concerned with international public health. It was established on 7 April 1948, headquartered in Geneva, Switzerland. The WHO is a member of the United Nations Development Group. Its predecessor, the Health Organization, was an agency of the League of Nations. The constitution of the World Health Organization had been signed by 61 countries on 22 July 1946, with the first meeting of the World Health Assembly finishing on 24 July 1948.

229, World Health Organization, Geneva

229, World Health Organization, Geneva. We aimed to characterize mycobacterial species causing pulmonary tuberculosis (PTB) and determine the resistance pattern to first line anti-TB drugs among newly diagnosed and previously treated PTB patients in Ghana.

Furthermore, these updated guidelines incorporate the wealth of experience gained from 15 years of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance (hereinafter, referred to as the Global Project), a project initiated by WHO and the International Union Against Tuberculosis and Lung Disease (The Union).

In 1994, the Global Tuberculosis Program of. the World Health Organization (WHO), with th. lished the Global Project on Anti-Tuberculosis. Drug Resistance Surveillance (hereafter referred. the World Health Organization (WHO), with the. support of the International Union against Tuber-. culosis and Lung Disease (the Union), estab-. to as the project ) to measure the magnitude of. drug resistance and to monitor trends. project remains the oldest and largest initiative. on the surveillance of antimicrobial resistance in. the world. 9. In this article, we describe the histor y. of global surveillance of drug resistance in tuber-.

Tuberculosis Drug Resistance Pulmonary Tuberculosis Tuberculosis Complex Tuberculosis Control .

Tuberculosis Drug Resistance Pulmonary Tuberculosis Tuberculosis Complex Tuberculosis Control Program. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves. 1. World Health Organization (2002) Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO/TB, GenevaGoogle Scholar.

Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung .

Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Lambregts-van Weezenbeek, M-L. Moro, F. Drobniewski, . ABSTRACT: Surveillance of antituberculosis drug resistance is an essential tool for evaluating the quality of tuberculosis control programmes. In 1994, a global initiative on antituberculosis drug resistance surveillance was launched by the World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD).

by World Health Organization. This is the third report of the WHO/IUATLD project which gives comparable worldwide information on anti-tuberculosis drug resistance, with data from surveys conducted in 77 different countries or geographical settings during the years 1999 to 2002. Global surveillance identifies areas of high resistance and draws the attention of national authorities to address the problems involved.

Surveillance of antituberculosis drug resistance is an essential tool for evaluating the quality of tuberculosis .

Surveillance of antituberculosis drug resistance is an essential tool for evaluating the quality of tuberculosis control programmes. Consensus-based recommendations on uniform reporting of antituberculosis drug resistance surveillance data in Europe have been developed by a Working Group of the World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD). Laboratories should use standardized methods for testing drug susceptibility with a quality assurance programme including national and international proficiency testing.